• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1600075 阿达木单抗注射液 adalimumab Injection Biological Products Import Drug Application 2016-12-30 AbbVie Inc. Abbvie Inc Certificate Issued 2017-12-20 view
JXSL1800049 输注用无菌冻干粉Telisotuzumab Vedotin telisotuzumab vedotin Lyophilized Biological Products Import Drug Application 2018-11-15 AbbVie Inc. Abbvie Inc In Review 2018-11-14 view
JXHS2000004 维奈克拉片 venetoclax Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 AbbVie Inc. Abbvie Inc Certificate Issued 2020-12-08 view
JXHS2000003 维奈克拉片 venetoclax Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 AbbVie Inc. Abbvie Inc Certificate Issued 2020-12-08 view
JXHS2000002 维奈克拉片 venetoclax Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 AbbVie Inc. Abbvie Inc Certificate Issued 2020-12-08 view
JYHB2000636 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-05-27 AbbVie Inc Abbvie Inc Filed 2020-06-09 view
JYHB2001571 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-08-25 AbbVie Inc Abbvie Inc Certificate Issued 2021-02-25 view
JYHB1900573 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2019-05-27 AbbVie Inc Abbvie Inc Certificate Issued 2021-02-25 view
JYHB1801470 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2018-12-13 AbbVie Inc Abbvie Inc Filed 2018-12-19 view
JYHZ1700300 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs License Renew 2018-01-19 AbbVie Inc Abbvie Inc Certificate Issued 2018-08-14 view
JYHB1500411 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-04-10 AbbVie Inc. Abbvie Inc Certificate Issued 2016-05-31 view
JYHB1501395 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-09-28 AbbVie Inc. Abbvie Inc Certificate Issued 2016-07-25 view
JYHB1700867 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-06-19 AbbVie Inc. Abbvie Inc Filed 2017-09-12 view
JYHB1400912 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2014-07-25 AbbVie Inc. Abbvie Inc Certificate Issued 2015-01-27 view
JYHB1601611 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2016-12-06 AbbVie Inc. Abbvie Inc Certificate Issued 2017-05-12 view
JYHB1700852 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-06-16 AbbVie Inc. Abbvie Inc Certificate Issued 2017-11-07 view
JYHB1500712 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-05-25 AbbVie Inc. Abbvie Inc Certificate Issued 2016-07-18 view
JYHB1501553 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-11-04 AbbVie Inc. Abbvie Inc Certificate Issued 2017-06-28 view
JYHB1701334 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-10-26 AbbVie Inc. Abbvie Inc Certificate Issued 2018-03-19 view
JXSL1500051 注射用ABT-414 depatuxizumab mafodotin Lyophilized Biological Products Import Drug Application 2015-09-02 AbbVie Inc. Abbvie Inc Certificate Issued 2017-04-06 view